Genmab A/S (CPH: GMAB)
Denmark
· Delayed Price · Currency is DKK 1,410.00
+16.00 (1.15%)
Jan 30, 2025, 4:59 PM CET
Genmab Market Cap
Genmab has a market cap or net worth of 89.57 billion as of January 30, 2025. Its market cap has decreased by -36.52% in one year.
Market Cap
89.57B
Enterprise Value
73.24B
Revenue
19.84B
Ranking
n/a
PE Ratio
19.53
Stock Price
1,410.00
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 3.68B to 89.57B, an increase of 2,331.16%. That is a compound annual growth rate of 14.03%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 2,711.73B |
| Coloplast | 186.46B |
| Demant | 62.48B |
| Zealand Pharma | 54.40B |
| H. Lundbeck | 39.78B |
| Ambu A/S | 36.31B |
| ALK-Abelló | 34.33B |
| GN Store Nord | 19.58B |